| | | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2024 ( Subtotal = $240,985,252 ) (Continued on the next page) |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01CA265981 | A novel, transferable sialylation-mediated mechanism of chemoradioresistance in GI cancer | 001 | 3 | NIH | 4/17/2024 | $19,327 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01CA265981 | A novel, transferable sialylation-mediated mechanism of chemoradioresistance in GI cancer | 000 | 3 | NIH | 1/5/2024 | $347,859 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | U01HL152978 | Therapeutic targeting of MUC5B in a novel ferret model of idiopathic pulmonary fibrosis | 001 | 4 | NIH | 6/24/2024 | $46,102 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | U01HL152978 | Therapeutic targeting of MUC5B in a novel ferret model of idiopathic pulmonary fibrosis | 000 | 4 | NIH | 11/21/2023 | $518,639 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | K23HD103875 | Close the GAP: Glycemic control after Antenatal corticosteroids in women with Pregestational diabetes | 000 | 4 | NIH | 11/29/2023 | $165,192 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AG075059 | The essentiality of serine and glycine for skeletal muscle regeneration in aging | 001 | 3 | NIH | 5/2/2024 | $42,196 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AG075059 | The essentiality of serine and glycine for skeletal muscle regeneration in aging | 000 | 3 | NIH | 11/15/2023 | $379,759 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01NS119479 | SULT4a1, a novel neuroprotective protein in stroke | 001 | 4 | NIH | 4/17/2024 | $26,933 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01NS119479 | SULT4a1, a novel neuroprotective protein in stroke | 000 | 4 | NIH | 12/1/2023 | $346,308 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01DK128132 | A novel link between gene regulation and histone modifications governing islet beta-cell development and function | 001 | 3 | NIH | 5/3/2024 | $27,434 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01DK128132 | A novel link between gene regulation and histone modifications governing islet beta-cell development and function | 000 | 3 | NIH | 11/22/2023 | $411,503 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01CA258248 | Credentialing next-generation human glioma models for precision therapeutics | 001 | 3 | NIH | 4/16/2024 | $28,154 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01CA258248 | Credentialing next-generation human glioma models for precision therapeutics | 000 | 3 | NIH | 12/11/2023 | $506,802 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AI172796 | Molecular mechanisms underlying organ penetration in disseminated pneumococcal infection | 001 | 2 | NIH | 5/13/2024 | $64,499 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH ST | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AI172796 | Molecular mechanisms underlying organ penetration in disseminated pneumococcal infection | 000 | 2 | NIH | 10/26/2023 | $580,491 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | F30AG085889 | Interactions between progranulin insufficiency and TDP-43 | 001 | 1 | NIH | 4/30/2024 | $1,280 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01CA259480 | MEF2D-Mediated Transcriptional Control of Acute Myeloid Leukemia | 001 | 3 | NIH | 4/17/2024 | $17,253 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01CA259480 | MEF2D-Mediated Transcriptional Control of Acute Myeloid Leukemia | 000 | 3 | NIH | 11/29/2023 | $310,541 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | F30AG085889 | Interactions between progranulin insufficiency and TDP-43 | 000 | 1 | NIH | 12/7/2023 | $41,349 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01CA265937 | Targeted delivery of multimodal therapy for reducing prostate cancer disparity | 001 | 3 | NIH | 4/17/2024 | $19,173 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01CA265937 | Targeted delivery of multimodal therapy for reducing prostate cancer disparity | 000 | 3 | NIH | 11/3/2023 | $345,094 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01EY032753 | ACE2 on gut barrier dysfunction and BRB disruption | 000 | 3 | NIH | 12/11/2023 | $369,431 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | K08HL157651 | Impaired Pneumococcal Antibody Function and Exacerbations of Chronic Obstructive Pulmonary Disease | 000 | 3 | NIH | 12/27/2023 | $161,261 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01DK134402 | Regulation of Macrophage Phenotype by Ferritin Heavy Chain in CKD | 001 | 2 | NIH | 5/24/2024 | $25,367 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01DK134402 | Regulation of Macrophage Phenotype by Ferritin Heavy Chain in CKD | 000 | 2 | NIH | 1/9/2024 | $380,518 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01EY033620 | Brain-gut-retina axis in diabetic retinopathy | 000 | 2 | NIH | 1/29/2024 | $532,390 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01CA269365 | ELAVL1 role in glioblastoma heterogeneity through intercellular gene transfer mediated by cell fusion and tunneling membrane nanotube formation | 001 | 2 | NIH | 4/16/2024 | $16,986 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01CA269365 | ELAVL1 role in glioblastoma heterogeneity through intercellular gene transfer mediated by cell fusion and tunneling membrane nanotube formation | 000 | 2 | NIH | 1/9/2024 | $305,724 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AI164717 | Mechanisms Controlling the Development and Function of Intestinal Effector Treg cells | 001 | 2 | NIH | 5/23/2024 | $72,969 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AI164717 | Mechanisms Controlling the Development and Function of Intestinal Effector Treg cells | 000 | 2 | NIH | 1/24/2024 | $656,710 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21EY035476 | Addressing Physical Activity Among Adults with Vision Impairment | 000 | 1 | NIH | 7/22/2024 | $408,368 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | M0141994 | Behavioral Health Workforce Education and Training Program | 00 | 4 | HRSA | 6/17/2024 | $458,196 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | 90IFRE0093 | Participation of People with Disabilities in Research: A Participatory Approach Mixed-Methods Study and Monitoring Dashboard | 00 | 1 | ACL | 7/15/2024 | $199,999 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | H1745461 | Healthy Tomorrows Partnership for Children Program | 01 | 3 | HRSA | 6/4/2024 | $31,131 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | H1745461 | Healthy Tomorrows Partnership for Children Program | 00 | 3 | HRSA | 1/26/2024 | $16,144 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21EB036277 | Ribozyme-mediated killing of cells harboring cancer driver mutations | 000 | 1 | NIH | 7/22/2024 | $185,133 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | D5740200 | Physician Assistant Training in Primary Care | 00 | 4 | HRSA | 5/9/2024 | $299,702 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01CA276683 | Development of Potent and non-toxic rexinoids to prevent non-melanoma skin cancer | 001 | 2 | NIH | 4/16/2024 | $30,506 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01CA276683 | Development of Potent and non-toxic rexinoids to prevent non-melanoma skin cancer | 000 | 2 | NIH | 1/24/2024 | $549,101 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01DK137506 | TARGETING MASH WITH NOVEL SMALL MOLECULE TXNIP INHIBITOR | 000 | 1 | NIH | 7/18/2024 | $629,249 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | F31GM150237 | Identifying Gestational-induced Changes in Islet Macrophages as a Potential Target for Beta-cell Expansion | 002 | 1 | NIH | 6/11/2024 | $1,280 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | F31GM150237 | Identifying Gestational-induced Changes in Islet Macrophages as a Potential Target for Beta-cell Expansion | 001 | 1 | NIH | 1/22/2024 | $0 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | F31GM150237 | Identifying Gestational-induced Changes in Islet Macrophages as a Potential Target for Beta-cell Expansion | 000 | 1 | NIH | 1/22/2024 | $40,647 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | P01HL158500 | Early Life Stress Induced Mechanisms of Cardiovascular Disease Risk and Resilience | 002 | 2 | NIH | 6/21/2024 | $178,899 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | P01HL158500 | Early Life Stress Induced Mechanisms of Cardiovascular Disease Risk and Resilience | 001 | 2 | NIH | 3/30/2024 | $0 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | P01HL158500 | Early Life Stress Induced Mechanisms of Cardiovascular Disease Risk and Resilience | 000 | 2 | NIH | 1/12/2024 | $2,012,602 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01MH135769 | "Determining the impact of peer-led community-based PrEP delivery among sexual and gender minority youth in Brazil: A randomized controlled trial" | 000 | 1 | NIH | 7/19/2024 | $560,305 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | E4C53208 | NSL - Baccalaureate Nursing | 000 | 1 | HRSA | 6/25/2024 | $70,000 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | E4D53212 | NSL - Graduate Nursing | 000 | 1 | HRSA | 6/28/2024 | $148,211 |
|